X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12961) 12961
Publication (2053) 2053
Newsletter (1215) 1215
Book Review (183) 183
Book / eBook (157) 157
Magazine Article (98) 98
Book Chapter (81) 81
Newspaper Article (72) 72
Trade Publication Article (53) 53
Conference Proceeding (46) 46
Dissertation (16) 16
Reference (3) 3
Web Resource (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9426) 9426
hiv (6580) 6580
index medicus (6029) 6029
animals (3992) 3992
immunology (3789) 3789
human immunodeficiency virus--hiv (3227) 3227
female (2795) 2795
male (2514) 2514
virology (2414) 2414
pharmacology & pharmacy (2392) 2392
aids (2286) 2286
human-immunodeficiency-virus (2281) 2281
health aspects (2090) 2090
infectious diseases (1958) 1958
infection (1945) 1945
hiv-1 - drug effects (1936) 1936
hiv infection (1902) 1902
medicine, research & experimental (1899) 1899
research (1842) 1842
adult (1789) 1789
infections (1751) 1751
mice (1736) 1736
viruses (1723) 1723
hiv-1 (1622) 1622
hiv infections - immunology (1608) 1608
vaccines (1603) 1603
proteins (1578) 1578
hiv infections - drug therapy (1572) 1572
virus diseases (1568) 1568
human immunodeficiency virus (1502) 1502
cell line (1464) 1464
antiviral agents (1441) 1441
hiv-1 - immunology (1437) 1437
anti-hiv agents - pharmacology (1361) 1361
cells, cultured (1346) 1346
research article (1342) 1342
analysis (1325) 1325
hiv-1 - physiology (1310) 1310
acquired immune deficiency syndrome--aids (1305) 1305
article (1291) 1291
medicine (1255) 1255
hiv infections - virology (1229) 1229
immunodeficiency-virus type-1 (1183) 1183
middle aged (1178) 1178
multidisciplinary sciences (1146) 1146
biochemistry & molecular biology (1134) 1134
hiv-1 - genetics (1119) 1119
microbiology (1108) 1108
medical research (1031) 1031
lymphocytes (1030) 1030
molecular sequence data (1001) 1001
antibodies (1000) 1000
t cells (965) 965
antiretroviral therapy (963) 963
drug therapy (952) 952
cell biology (933) 933
science (922) 922
expression (886) 886
amino acid sequence (885) 885
virus replication - drug effects (880) 880
in-vitro (799) 799
allergy and immunology (785) 785
replication (783) 783
hiv infections - prevention & control (779) 779
aids vaccines - immunology (768) 768
antigens (765) 765
vaccination (749) 749
studies (741) 741
biology (729) 729
aids vaccines (727) 727
immunization (717) 717
physiological aspects (717) 717
gene expression (705) 705
pharmacology (705) 705
acquired immune deficiency syndrome (703) 703
prevention (699) 699
immune system (697) 697
neurosciences (693) 693
activation (685) 685
cells (665) 665
t-cells (658) 658
cytokines (654) 654
antiviral agents - pharmacology (649) 649
highly active antiretroviral therapy (648) 648
apoptosis (645) 645
immune response (624) 624
medicine, experimental (621) 621
peptides (616) 616
hiv infections - complications (613) 613
anti-hiv agents - therapeutic use (612) 612
risk factors (609) 609
viral load (593) 593
care and treatment (587) 587
flow cytometry (585) 585
hiv patients (568) 568
antiretroviral drugs (564) 564
mice, inbred balb c (559) 559
therapy (558) 558
in-vivo (557) 557
enzyme-linked immunosorbent assay (552) 552
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (106) 106
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Online Resources - Online (10) 10
UofT at Scarborough - Stacks (9) 9
New College (Ivey) - Stacks (4) 4
Robarts - Stacks (4) 4
Toronto East General Hospital - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
UofT at Mississauga - Stacks (4) 4
Credit Valley Hospital - Stacks (3) 3
Gerstein Science - Reference (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Thomas Fisher Rare Book - Rare Book (3) 3
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Providence Healthcare - Reference (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Gerstein Science - Missing (1) 1
Knox College (Caven) - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Course Reserves (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14550) 14550
Spanish (17) 17
German (11) 11
Japanese (11) 11
French (9) 9
Russian (9) 9
Chinese (7) 7
Dutch (3) 3
Italian (3) 3
Portuguese (3) 3
Turkish (3) 3
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 515, Issue 7525, pp. 138 - 142
The isolation of human monoclonal antibodies is providing important insights into the specificities that underlie broad neutralization of HIV-1 (reviewed in... 
B-CELLS | SPECIFICITIES | MULTIDISCIPLINARY SCIENCES | SERA | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | VULNERABILITY | GP120 | HUMAN MONOCLONAL-ANTIBODIES | CLEAVAGE | DEPENDENT EPITOPE | Immunoglobulin Fab Fragments - ultrastructure | Antibody Specificity | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Leukocytes, Mononuclear | HIV Envelope Protein gp41 - chemistry | Virus Internalization - drug effects | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | Conserved Sequence | Inhibitory Concentration 50 | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Cell Line | Immunoglobulin Fab Fragments - genetics | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | Models, Molecular | Antibodies, Neutralizing - pharmacology | Antibody Affinity | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Antibodies, Monoclonal - genetics | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Cell Membrane - virology | Epitopes - chemistry | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | CD4 Antigens - metabolism | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Genetic aspects | Research | HIV infection | Antigenic determinants | Amino acids | Mutation | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Index Medicus
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2017, Volume 23, Issue 2, pp. 185 - 191
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 877 - 12
HIV-1 broadly neutralizing antibodies (bNAbs) are being explored as passively administered therapeutic and preventative agents. However, the extensively... 
BISPECIFIC ANTIBODIES | SHIV INFECTION | POTENT NEUTRALIZATION | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | IMPROVES PROTECTION | CD4 BINDING | HUMAN MONOCLONAL-ANTIBODIES | HUMAN-IMMUNODEFICIENCY-VIRUS | FITNESS COST | BREADTH | Protein Subunits - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | Antiviral Agents - immunology | Humans | Epitopes - immunology | Antibodies, Neutralizing - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV Antibodies - immunology | Antiviral Agents - chemistry | Antibodies, Neutralizing - therapeutic use | env Gene Products, Human Immunodeficiency Virus - antagonists & inhibitors | Drug Design | Single-Chain Antibodies - therapeutic use | HIV Antibodies - therapeutic use | HIV Antibodies - pharmacology | Antiviral Agents - pharmacology | Single-Chain Antibodies - pharmacology | Antiviral Agents - therapeutic use | HIV-1 - drug effects | Antibodies, Neutralizing - pharmacology | Epitopes - genetics | HIV-1 - genetics | Microscopy, Electron | HIV Antibodies - chemistry | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | HIV Infections - drug therapy | Mutation | Drug Combinations | Single-Chain Antibodies - chemistry | Single-Chain Antibodies - immunology | Antiviral agents | Antibodies | Crosslinking | Glycoproteins | Pharmacology | Epitopes | Chemical compounds | Glycan | CD4 antigen | Human immunodeficiency virus--HIV | Avidity | Binding sites | Neutralization
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2012, Volume 109, Issue 31, pp. 12680 - 12685
The constant heavy chain (CH1) domain affects antibody affinity and fine specificity, challenging the paradigm that only variable regions contribute to antigen... 
T lymphocytes | Isotypes | HIV | Epithelial cells | Antibodies | Viruses | Transcytosis | Infections | Epitopes | HIV 1 | Antibody structure | HIV-1 envelope gp41 | Mimotope | Mucosa | HIV-1 | DENDRITIC CELLS | SERONEGATIVE INDIVIDUALS | MULTIDISCIPLINARY SCIENCES | GP41 | HUMAN MONOCLONAL-ANTIBODY | HUMAN-IMMUNODEFICIENCY-VIRUS | EPITHELIAL TRANSCYTOSIS | antibody structure | ANTIGEN-BINDING AFFINITY | mimotope | REGION | TYPE-1 | mucosa | Antibody Specificity | HIV Envelope Protein gp41 - genetics | HIV-1 - pathogenicity | HIV Envelope Protein gp41 - immunology | Humans | Acquired Immunodeficiency Syndrome - therapy | CD4-Positive T-Lymphocytes - immunology | Epitopes - immunology | Acquired Immunodeficiency Syndrome - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Immunoglobulin G - pharmacology | CD4-Positive T-Lymphocytes - virology | HIV Antibodies - pharmacology | Acquired Immunodeficiency Syndrome - transmission | Protein Structure, Secondary | Antibodies, Monoclonal - pharmacology | Cells, Cultured | Antibodies, Neutralizing - pharmacology | Antibodies, Neutralizing - genetics | Transcytosis - immunology | Epitopes - genetics | HIV-1 - genetics | Antibodies, Monoclonal - genetics | HIV-1 - immunology | Immunoglobulin G - genetics | Transcytosis - drug effects | Antibodies, Monoclonal - metabolism | HIV Antibodies - genetics | Viral antibodies | Antiviral agents | Physiological aspects | Research | Health aspects | Protein binding | Life Sciences | Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2013, Volume 110, Issue 33, pp. 13540 - 13545
Journal Article